The Justice Department filed a complaint Thursday in the Southern District of Florida seeking to strip U.S. citizenship from Victor Manuel Rocha, a former American ambassador who admitted to spying for Cuba, The Hill reports. The government's theory: Rocha illegally obtained naturalization by misrepresenting himself during the citizenship process — making the denaturalization claim procedural, not punitive.

That distinction matters enormously. The administration is field-testing a legal pathway to revoke citizenship via civil complaint — no criminal conviction required beyond the underlying fraud in the naturalization process. Rocha is the easiest possible target: a confessed foreign agent, zero public sympathy.

Hardest case first, then expand the tool kit. That's the play. A DOJ that wins on Rocha owns a precedent it can cite against a much longer list of people who are not confessed spies.

Louisiana filed a brief urging the Supreme Court to uphold the 5th Circuit's nationwide block on mailing mifepristone — the drug used in roughly two-thirds of U.S. abortions — while the Trump DOJ submitted nothing, even though the federal government is a named defendant in the case. Justice Alito's temporary pause of the 5th Circuit order expires Monday at 5 p.m. EDT.

Said Deirdre Schifeling, chief political and advocacy officer at the ACLU: "The administration's silence speaks volumes and is a permission slip to the Supreme Court to restrict access to medication abortion nationwide, betraying decades of science and President Trump's campaign promises not to impose new federal restrictions on abortion."

Read the play: the White House avoids ownership while Louisiana does the work. If SCOTUS reinstates the in-person requirement, Trump claims clean hands. If Alito's pause holds, the base gets strung along. Either way, the administration collects the benefit without filing a single page.

The Trump administration has moved to denaturalize 12 Americans, citing fraud or other disqualifying misconduct, the New York Times reports. The targets are accused of conduct that legally can support denaturalization — but the administration's own framing concedes the tool has rarely been invoked in American history.

Here's the strategic read: you don't open with 12. You open with 12 to establish the legal infrastructure, win the cases no one will defend hard, and normalize the precedent. The population of people vulnerable to a broader campaign is orders of magnitude larger.

Denaturalization as a political instrument inverts the constitutional presumption that citizenship, once granted, is secure. That inversion is the point — not the 12.

ABC filed with the FCC on Friday accusing the commission of violating its First Amendment rights, as Chairman Brendan Carr escalates regulatory scrutiny of Disney-owned ABC over broadcast content — including programming on "The View" and Jimmy Kimmel's show — according to reporting first published by the New York Times.

The play here is transparent: use license-renewal leverage to discipline a network whose on-air talent criticizes the president. You don't need to revoke anything. The threat alone is the mechanism — chilling editorial decisions across the industry while the litigation crawls.

The constitutional problem is straightforward. The FCC's mandate is spectrum management, not content curation for the executive branch. When a regulator's complaint calendar tracks the president's enemies list, that's not enforcement — it's a shakedown in regulatory clothing.

Moshe Marvit, a Biden-appointed member of the Federal Mine Safety and Health Review Commission, sued President Trump Thursday after being fired without a stated cause, The Hill reports. Marvit — an attorney with a background in workers' rights law — argues the termination was illegal under the statute governing the commission.

The firing notice cited no reason. That detail matters: Congress wrote for-cause removal protections into independent commission structures precisely to insulate them from political pressure. Trump's play here isn't subtle — fire first, litigate second, and let a sympathetic Supreme Court majority ratify the expansion of presidential control over agencies Congress built to be independent.

This is the same theory that's already been tested against the NLRB and the FTC. Every new lawsuit in this pattern is a data point in a larger argument: that the president's removal power is effectively unlimited. The courts haven't fully signed off yet. That's the whole game.

A federal judge in Manhattan ruled Thursday that the Trump administration's cancellation of more than $100 million in National Endowment for the Humanities grants was unconstitutional — permanently barring the administration from terminating the funding, per NBC News.

Said Judge Colleen McMahon: "The public has a strong interest in ensuring that federal officials act within the bounds set by Congress and the Constitution."

The ruling lands on a question older than DOGE and older than Trump: whether a president can simply stop spending money Congress has already appropriated. The answer, across two and a half centuries of American constitutional practice, has always been no.

U.S. and Iranian forces exchanged fire in the Strait of Hormuz after Iranian forces targeted American destroyers and the U.S. responded with strikes on Iranian military assets, per The Bulwark (May 8). Active combat at sea — and the administration is calling it a ceasefire.

Said Trump, per The Bulwark's Tim Miller: the exchange was a "love tap" and the ceasefire remains "intact." That framing isn't spin for Tehran — it's spin for Congress. If it's a love tap, it's not hostilities. If it's not hostilities, the War Powers Clock doesn't start.

The play here: hold oil markets steady, avoid a floor vote on authorizing force, and keep the conflict legally ambiguous long enough to negotiate or escalate on Trump's timeline. Congress should be demanding a legal classification in writing — today. The Strait of Hormuz handles roughly 20 percent of global oil trade. "Love tap" is doing a lot of work.

The Trump administration filed a proposed rule last month that would allow handguns — pistols and revolvers — to be mailed through the United States Postal Service to anyone in the country, The Hill reports. Current federal law bans handgun shipments through the mail; the proposal would extend to concealable firearms the same framework that already governs long-barreled rifles and shotguns.

The play here is straightforward: this is executive rulemaking doing what Congress won't. Bypassing the legislative process to expand gun-shipping rights avoids a floor vote, avoids a filibuster, and avoids any Republican having to cast a recorded yes on loosening handgun law before the midterms.

The strategic beneficiaries are gun-industry logistics networks and any buyer who currently relies on licensed dealer transfers. The constitutional exposure is real: a federal agency using rulemaking authority to override a statutory prohibition is exactly the kind of overreach that invites a major questions doctrine challenge — if anyone bothers to bring it.

Louisiana has asked the Supreme Court to halt mail access to mifepristone, the abortion pill, according to reporting by The New York Times (May 7, 2026). The move follows a federal appeals court ruling that temporarily blocked an FDA regulation which had substantially expanded mail-order access to the drug.

The long-arc context matters here. The legal theory underlying these challenges — that federal postal statutes can be used to ban the mailing of abortion-related materials — traces directly to the Comstock Act of 1873, a law Congress passed to suppress obscenity through the mails and which advocates of abortion restriction have worked for years to revive as a national prohibition mechanism. That strategy now has a federal appellate foothold.

Every time Congress has given a single federal agency the power to choke off a constitutional right through administrative action, the courts have eventually been forced to draw a line. Where they draw it this time will determine whether FDA drug approvals still mean what they say.